Your browser doesn't support javascript.
loading
Is Ozone therapy an adjunct treatment for SARS-CoV-2 / COVID-19 infection?
Arias-Vázquez, Pedro Iván; Arcila-Novelo, Russell; Ramírez-Wakamatzu, María Antonieta.
  • Arias-Vázquez, Pedro Iván; Juarez Autonomous University of Tabasco. Comalcalco Tabasco. MX
  • Arcila-Novelo, Russell; Autonomous University of Yucatan. Merida. MX
  • Ramírez-Wakamatzu, María Antonieta; Medical Center Aruku. Mexico City. MX
Braz. J. Pharm. Sci. (Online) ; 58: e20775, 2022. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1403724
ABSTRACT
Abstract Up to today, there is no specific treatment against SARS-CoV-2 / COVID-19 infection; there the necessity to search for alternatives that help patients with COVID-19. The objective of this study was to review the use of ozone therapy as adjunct treatment for SARS-CoV-2 / COVID-19 infection, highlighting the mechanisms of action, forms of application and current clinical evidence. A systematic review was conducted in electronic databases, searching the terminology Ozone "or" Ozone therapy "and" SARS-CoV-2 or COVID-19 or Coronavirus.

Results:

nineteen studies were included; ten were editorials, comments, brief reports or reviews, and nine clinical studies. We found that ozone therapy could be favorable for treating patients infected with SARS-CoV-2 / COVID-19, through a direct antiviral effect, regulation of oxidative stress, immunomodulation and improvement of oxygen metabolism. Patients who were treated with ozone therapy responded favorably; therefore, ozone therapy appears to be a promising treatment for patients infected with SARS-CoV-2 / COVID-19. Its mechanism of action justifies its use as an adjuvant therapy; however, scientific evidence is based on case series and clinical trials are necessary to corroborate its effectiveness and safety.
Assuntos


Texto completo: DisponíveL Índice: LILACS (Américas) Assunto principal: Coronavirus / SARS-CoV-2 / COVID-19 / Ozonioterapia Tipo de estudo: Revisões Sistemáticas Avaliadas Idioma: Inglês Revista: Braz. J. Pharm. Sci. (Online) Assunto da revista: Farmacologia / Terapˆutica / Toxicologia Ano de publicação: 2022 Tipo de documento: Artigo País de afiliação: México Instituição/País de afiliação: Autonomous University of Yucatan/MX / Juarez Autonomous University of Tabasco/MX / Medical Center Aruku/MX

Similares

MEDLINE

...
LILACS

LIS


Texto completo: DisponíveL Índice: LILACS (Américas) Assunto principal: Coronavirus / SARS-CoV-2 / COVID-19 / Ozonioterapia Tipo de estudo: Revisões Sistemáticas Avaliadas Idioma: Inglês Revista: Braz. J. Pharm. Sci. (Online) Assunto da revista: Farmacologia / Terapˆutica / Toxicologia Ano de publicação: 2022 Tipo de documento: Artigo País de afiliação: México Instituição/País de afiliação: Autonomous University of Yucatan/MX / Juarez Autonomous University of Tabasco/MX / Medical Center Aruku/MX